Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Invivyd, Inc. - Common Stock
(NQ:
IVVD
)
0.9201
-0.3699 (-28.67%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,609,313
Open
1.290
Bid (Size)
0.9400 (4)
Ask (Size)
0.9700 (11)
Prev. Close
1.290
Today's Range
0.9008 - 1.320
52wk Range
0.8368 - 5.195
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Invivyd Announces PEMGARDA™ (pemivibart) Demonstrated 84% Relative Risk Reduction in Symptomatic COVID-19 Compared to Placebo in an Exploratory Analysis from Ongoing CANOPY Phase 3 Clinical Trial
August 27, 2024
From
Invivyd
Via
GlobeNewswire
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 21, 2024
Via
Benzinga
Performance
YTD
-74.79%
-74.79%
1 Month
-24.58%
-24.58%
3 Month
-47.72%
-47.72%
6 Month
-78.50%
-78.50%
1 Year
-49.17%
-49.17%
More News
Read More
IVVD Stock Earnings: Invivyd Misses EPS, Misses Revenue for Q2 2024
August 14, 2024
Via
InvestorPlace
Invivyd Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 14, 2024
From
Invivyd
Via
GlobeNewswire
IVVD Stock Earnings: Invivyd Meets EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
IVVD Stock Earnings: Invivyd Misses EPS for Q4 2023
March 28, 2024
Via
InvestorPlace
Invivyd to Host Conference Call Discussing Second Quarter 2024 Financial Results and Business Highlights
August 12, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Announces its Addition to the Russell 2000® and Russell 3000® Indexes
July 01, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Announces Antiviral Activity of VYD222 (pemivibart) Against SARS-CoV-2 KP.1.1 FLiRT & KP.3 Variants
June 14, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd: Q4 Earnings Insights
March 28, 2024
Via
Benzinga
Invivyd to Participate at the Jefferies Global Healthcare Conference
June 03, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Announces General Alignment with U.S. FDA on a Repeatable, Expedient Emergency Use Authorization Pathway for the Prevention and Treatment of Symptomatic COVID-19, Based on Compact Clinical Programs to Establish Safety and Immunobridging for Serial
May 31, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Announces the Appointment of Timothy Lee as Chief Commercial Officer
May 31, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd to Present Data at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting and 2024 American Transplant Congress (ATC)
May 29, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Elects Two New Independent Members to its Board of Directors
May 22, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA Feedback
May 07, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
May 02, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position
April 30, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
April 15, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Announces CEO Transition
April 12, 2024
From
Invivyd
Via
GlobeNewswire
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
April 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million
April 04, 2024
From
Invivyd
Via
GlobeNewswire
Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
March 28, 2024
From
Invivyd
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
